Treatment Disparities

Risks & contraindications

Comparisons

Evidence quality

Highlighted claims

• This study adds qualitative detail about possible decision-making influences on disparities but does not prove that patient preferences or barriers explain the treatment differences observed. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Evidence indicates that South Asian patients receive different IBD treatments than white patients in Western countries. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Prior studies have documented that South Asian IBD patients have lower use of surgery, lower prescription of thiopurines and multiple biologics, more corticosteroid use, and delayed initiation of advanced therapy. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Treatment differences between South Asian and white IBD patients are associated with poorer outcomes, including disease progression and increased need for surgery. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada
• Immigration-related concerns as a driver of healthcare disparities deserve dedicated study among immigrants, refugees, and newcomers. — A cultural lens on decision-making in treatment decisions about inflammatory bowel disease: a qualitative analysis with South Asian patients, caregivers and clinicians in Canada